Company Encyclopedia
View More
name
ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS
ADAPY.US
1.945 T
ADAPY.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
E
BiotechnologyIndustry
Industry Ranking383/394
Industry medianC
Industry averageD
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreE
    • ROE-1341.10%E
    • Profit Margin-260.82%E
    • Gross Margin-86.30%E
  • Growth ScoreE
    • Revenue YoY-53.99%E
    • Net Profit YoY-134.15%E
    • Total Assets YoY-59.39%E
    • Net Assets YoY-173.70%E
  • Cash ScoreE
    • Cash Flow Margin-38.34%D
    • OCF YoY-53.99%E
  • Operating ScoreD
    • Turnover0.29D
  • Debt ScoreE
    • Gearing Ratio154.32%E

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Adaptimmune Announces Changes to Board and Executive Leadership Team

    Adaptimmune Therapeutics plc announced changes to its Board and Executive Leadership Team effective November 14, 2025. Chris Hill, previously CFO, is now CEO and Director, succeeding Adrian Rawcliffe. Lawrence Alleva is appointed Chairman, replacing David Mott. The company delisted from Nasdaq and is quoted on OTC Pink. The restructuring follows a transaction with US WorldMeds and aims to maximize asset value while reducing public company costs.

    Newsfile Corp.·
    US
    ADAP
    0.00%
    Newsfile Corp.·
    US
    ADAP
    0.00%

    12 Health Care Stocks Moving In Monday's After-Market Session

    In Monday's after-market session, several health care stocks saw significant movements. Pulmonx (NASDAQ:LUNG) surged 47.4% to $2.3, with a market cap of $65.2 million. ETHZilla (NASDAQ:ETHZ) rose 10.41% to $22.8, valued at $298.8 million. Adaptimmune Therapeutics (NASDAQ:ADAP) increased 9.28% to $0.06, with a market cap of $17.1 million. Kindly MD (NASDAQ:NAKA) gained 7.92% to $1.09, valued at $347.4 million. Radiopharm Theranostics (NASDAQ:RADX) shares rose 7.78% to $5.5, with a market cap of $41.4 million. Traws Pharma (NASDAQ:TRAW) increased 7.69% to $2.8, valued at $19.3 million.

    Benzinga·
    US
    NAKA
    -6.84%
    US
    TRAW
    +0.42%
    US
    RADX
    +4.68%
    Benzinga·
    US
    NAKA
    -6.84%
    US
    TRAW
    +0.42%
    US
    RADX
    +4.68%

    Adaptimmune Announces Delisting from Nasdaq | ADAP Stock News

    Adaptimmune Therapeutics plc announced its decision to delist its American Depositary Shares (ADSs) from Nasdaq and deregister under the Securities Exchange Act. This move follows a strategic review and aims to reduce costs while maximizing value from remaining assets. The delisting is expected to take effect around October 27, 2025, with trading potentially continuing on the OTC Pink Limited Market. The Board believes this decision is in the best interest of the company and its shareholders, citing the burdens of being a public company as a key factor.

    StockTitan·
    US
    ADAP
    0.00%
    US
    ADAPY
    +11.96%
    StockTitan·
    US
    ADAP
    0.00%
    US
    ADAPY
    +11.96%

    Pre-market hot trades in US stocks: Adaptimmune Therap pre-market down 10.50%; Annovis Bio pre-market down 9.09%

    Adaptimmune Therap fell 10.50% in pre-market; Annovis Bio fell 9.09% in pre-market; ESS Tech rose 128.49% in pre-market; Safe & Green rose 91.63% in pre-market; Leifras rose 55.63% in pre-market

    Tracking Unusual Activity·
    US
    ADAP
    0.00%
    US
    ANVS
    +0.43%
    US
    ADAPY
    +11.96%
    Tracking Unusual Activity·
    US
    ADAP
    0.00%
    US
    ANVS
    +0.43%
    US
    ADAPY
    +11.96%

    U.S. Stock Market Midday Update: Adaptimmune Therap rises 13.35%

    Adaptimmune Therap rose 13.35%; Akero Therapeutics rose 16.47%, with a transaction volume of USD 1.679 billion; AbbVie rose 0.09%, with a transaction volume of USD 470 million; Global Health Solutions rose 26.71%, with a transaction volume of 370,599,507; Biodexa Pharmaceuticals rose 37.09%, with a market value of USD 65.48 billion

    Tracking Unusual Activity·
    US
    ADAP
    0.00%
    US
    ADAPY
    +11.96%
    Tracking Unusual Activity·
    US
    ADAP
    0.00%
    US
    ADAPY
    +11.96%
    © 2025 Longbridge｜Disclaimer